BoobyBiome

Based in the UK, BoobyBiome specializes in probiotic solutions derived from breast milk, aiming to enhance infant health by delivering essential beneficial bacteria for gut and immune support. Founded in 2019 and headquartered in London, UK, BoobyBiome focuses on microbiome health solutions for infants. The company has successfully pivoted to enhance its product offerings and has engaged in one investment deal. The most recent investment was a SEED round in September 2025, where the company raised EUR 2.

8 mn, led by Empirical Ventures along with other investors, bringing the total amount raised to EUR 2. 8 mn. BoobyBiome's primary offerings include innovative microbiome solutions derived from breast milk, designed to provide infants with the beneficial bacteria necessary for promoting gut health and immune development. The company targets healthcare professionals, parents, and lactating mothers in markets such as the UK, the US, and select European countries.

It collaborates with a community of mothers for breast milk donations, enriching its research and product development. Revenue for BoobyBiome comes from direct-to-consumer sales of its microbiome products and strategic partnerships with healthcare providers and retailers. The company offers individual products and may provide subscription services to ensure continuous supply, catering to the needs of families seeking essential microbiome solutions. In September 2025, BoobyBiome raised EUR 2.

8 mn in SEED funding led by Empirical Ventures. The company plans to utilize this funding to launch its breast milk storage device and advance the development of its live microbiome drop. Additionally, BoobyBiome aims to strengthen its team to facilitate global expansion into new markets, enhancing its product portfolio and reach.